NDC 0591-3204

Podofilox

Podofilox

Podofilox is a Topical Solution in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Podofilox.

Product ID0591-3204_5766dbf4-7685-44be-b45b-cee2076b8fee
NDC0591-3204
Product TypeHuman Prescription Drug
Proprietary NamePodofilox
Generic NamePodofilox
Dosage FormSolution
Route of AdministrationTOPICAL
Marketing Start Date1990-12-13
Marketing CategoryNDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC
Application NumberNDA019795
Labeler NameActavis Pharma, Inc.
Substance NamePODOFILOX
Active Ingredient Strength5 mg/mL
Pharm ClassesDecreased Mitosis [PE]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0591-3204-13

3.5 mL in 1 BOTTLE, GLASS (0591-3204-13)
Marketing Start Date1990-12-13
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0591-3204-13 [00591320413]

Podofilox SOLUTION
Marketing CategoryNDA AUTHORIZED GENERIC
Application NumberNDA019795
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1990-12-13

Drug Details

Active Ingredients

IngredientStrength
PODOFILOX5 mg/mL

OpenFDA Data

SPL SET ID:affc1058-7355-4486-8b65-378fea6f9454
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 582926
  • Pharmacological Class

    • Decreased Mitosis [PE]
    • Decreased Mitosis [PE]

    NDC Crossover Matching brand name "Podofilox" or generic name "Podofilox"

    NDCBrand NameGeneric Name
    0574-0611PODOFILOXPODOFILOX
    0591-3204PodofiloxPodofilox
    63629-8832PodofiloxPodofilox
    0023-6118Condyloxpodofilox

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.